Affini-T
is a Massachusetts-based biotechnology company that researches and commercializes T cell therapies for the treatment of cancer and immune disorders... Read moreAffini-T
is a Massachusetts-based biotechnology company that researches and commercializes T cell therapies for the treatment of cancer and immune disorders... Read more
News
Apr 24, 2025
EIN Presswire
Press Release: Affini-T : Affini-T Therapeutics Presents Preclinical Data from its Programs Targeting Oncogenic Drivers KRAS and TP53 at AACR
Jan 27, 2025
Endpoints News
Affini-T: Cell therapy biotech Affini-T Therapeutics appears to cut staff
Jan 09, 2025
Business Wire
Press Release: Affini-T : Affini-T Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Nov 06, 2024
Business Wire
Press Release: Affini-T : Affini-T Therapeutics to Present Trial-in-Progress Poster and Preclinical Data from Its Oncogenic Driver Programs Targeting TP53 R175H, KRAS G12D and KRAS-G12V at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
May 28, 2024
Business Wire
Press Release: Affini-T : Affini-T Therapeutics Announces First Patient Dosed in KRAS G12V Phase 1 Program and Presentation of Trial-in-Progress Poster at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
May 01, 2024
StreetInsider
Press Release: Affini-T : Affini-T Therapeutics to Present Data From Its Preclinical Programs Targeting KRAS G12D and TP53 R175H at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting
Apr 23, 2024
Pharamceutical Technology
Affini-T: AFNT-211 by Affini-T Therapeutics for Colorectal Cancer: Likelihood of Approval
Apr 07, 2024
Business Wire
Press Release: Affini-T : Affini-T Therapeutics Presents Preclinical Data from its Oncogenic Driver Programs Targeting KRAS G12D and p53 R175H at the American Association for Cancer Research (AACR) Annual Meeting 2024
Mar 13, 2024
Business Wire
Affini-T: Affini-T Therapeutics to Present Preclinical Data from its Programs Targeting KRAS G12D and p53 R175H and Two Trials in Progress at the American Association for Cancer Research (AACR) Annual Meeting
Jan 07, 2024
Benzinga
Affini-T: Affini-T Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
